Jaguar Health Inc.

NASDAQ: JAGX · Real-Time Price · USD
2.08
0.01 (0.48%)
At close: Aug 15, 2025, 3:59 PM
2.18
4.56%
After-hours: Aug 15, 2025, 05:38 PM EDT

Jaguar Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
11.69M 9.76M 11.96M 4.33M
Cost of Revenue
1.96M 2.04M 2.02M 2.33M
Gross Profit
9.73M 7.72M 9.94M 2M
Operating Income
-30.83M -34.29M -34.41M -39.07M
Interest Income
n/a n/a n/a 8.42M
Pretax Income
-39.25M -41.9M -48.4M -52.6M
Net Income
-38.49M -41.3M -47.45M -60.25M
Selling & General & Admin
24.02M 23.05M 26.7M 26M
Research & Development
16.54M 18.6M 17.65M 15.08M
Other Expenses
n/a 371K n/a n/a
Operating Expenses
40.56M 42.02M 44.35M 41.08M
Interest Expense
231K 6.38M 12.72M 8.42M
Selling & Marketing Expenses
7.69M 6.46M 8.84M 8.89M
Cost & Expenses
42.52M 44.05M 46.37M 43.41M
Income Tax Expense
n/a n/a n/a 7.65M
Shares Outstanding (Basic)
294.53K 15.42K 11.69 5.31
Shares Outstanding (Diluted)
294.53K 15.42K 11.69 5.31
EPS (Basic)
-130.69 -2.69K -4.07M -11.37M
EPS (Diluted)
-130.69 -2.69K -4.07M -11.37M
EBITDA
-36.66M -33.13M -33.38M -42.35M
EBIT
-39.02M -33.92M -35.67M -44.18M
Depreciation & Amortization
2.36M 1.16M 2.29M 1.83M